IRIS Accounts Production v24.1.0.578 06366199 director 28.2.23 1.3.22 28.2.23 28.2.23 the provision of quality care home facilities from five homes in the East Riding of Yorkshire and North Yorkshire. true true true false true true false false false false true false Ordinary 0 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh063661992022-02-28063661992023-02-28063661992022-03-012023-02-28063661992021-02-28063661992021-03-012022-02-28063661992022-02-2806366199ns15:EnglandWales2022-03-012023-02-2806366199ns14:PoundSterling2022-03-012023-02-2806366199ns10:Director12022-03-012023-02-2806366199ns10:Consolidated2023-02-2806366199ns10:ConsolidatedGroupCompanyAccounts2022-03-012023-02-2806366199ns10:PrivateLimitedCompanyLtd2022-03-012023-02-2806366199ns10:Consolidatedns10:FRS1022022-03-012023-02-2806366199ns10:Consolidatedns10:Audited2022-03-012023-02-2806366199ns10:LargeMedium-sizedCompaniesRegimeForDirectorsReport2022-03-012023-02-2806366199ns10:LargeMedium-sizedCompaniesRegimeForAccounts2022-03-012023-02-2806366199ns10:Consolidatedns10:LargeMedium-sizedCompaniesRegimeForDirectorsReport2022-03-012023-02-2806366199ns10:LargeMedium-sizedCompaniesRegimeForAccountsns10:Consolidated2022-03-012023-02-2806366199ns10:FullAccounts2022-03-012023-02-2806366199ns5:Subsidiary12022-03-012023-02-280636619912022-03-012023-02-2806366199ns10:OrdinaryShareClass12022-03-012023-02-2806366199ns10:Consolidated2022-03-012023-02-2806366199ns10:RegisteredOffice2022-03-012023-02-2806366199ns10:Consolidated2021-03-012022-02-2806366199ns5:CurrentFinancialInstruments2023-02-2806366199ns5:CurrentFinancialInstruments2022-02-2806366199ns5:Non-currentFinancialInstruments2023-02-2806366199ns5:Non-currentFinancialInstruments2022-02-2806366199ns5:ShareCapital2023-02-2806366199ns5:ShareCapital2022-02-2806366199ns5:RetainedEarningsAccumulatedLosses2023-02-2806366199ns5:RetainedEarningsAccumulatedLosses2022-02-2806366199ns5:ShareCapital2021-02-2806366199ns5:RetainedEarningsAccumulatedLosses2021-02-2806366199ns5:RetainedEarningsAccumulatedLosses2021-03-012022-02-2806366199ns5:RetainedEarningsAccumulatedLosses2022-03-012023-02-2806366199ns5:IntangibleAssetsOtherThanGoodwill2022-03-012023-02-2806366199ns5:OwnedOrFreeholdAssetsns5:LandBuildings2022-03-012023-02-2806366199ns5:FurnitureFittings2022-03-012023-02-2806366199ns5:MotorVehicles2022-03-012023-02-2806366199ns5:ComputerEquipment2022-03-012023-02-2806366199ns5:FurnitureFittings2022-02-2806366199ns5:MotorVehicles2022-02-2806366199ns5:ComputerEquipment2022-02-2806366199ns5:FurnitureFittings2023-02-2806366199ns5:MotorVehicles2023-02-2806366199ns5:ComputerEquipment2023-02-2806366199ns5:FurnitureFittings2022-02-2806366199ns5:MotorVehicles2022-02-2806366199ns5:ComputerEquipment2022-02-2806366199ns5:CostValuation2022-02-2806366199ns5:Subsidiary112022-03-012023-02-2806366199ns5:Subsidiary12023-02-2806366199ns5:Subsidiary12022-02-2806366199ns5:Subsidiary12021-03-012022-02-2806366199ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-02-2806366199ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-02-2806366199ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2023-02-2806366199ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2022-02-2806366199ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-02-2806366199ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2022-02-2806366199ns5:Secured2023-02-2806366199ns5:Secured2022-02-2806366199ns5:DeferredTaxation2022-02-2806366199ns5:DeferredTaxation2023-02-2806366199ns10:OrdinaryShareClass12023-02-2806366199ns5:RetainedEarningsAccumulatedLosses2022-02-28
REGISTERED NUMBER: 06366199 (England and Wales)
























GROUP STRATEGIC REPORT,

REPORT OF THE DIRECTOR AND

CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 28 FEBRUARY 2023

FOR

SABRINA HEALTH CARE LIMITED

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

CONTENTS OF THE CONSOLIDATED FINANCIAL STATEMENTS
For The Year Ended 28 February 2023










Page

Company Information 1

Group Strategic Report 2

Report of the Director 3

Report of the Independent Auditors 5

Consolidated Statement of Comprehensive Income 8

Consolidated Balance Sheet 9

Company Balance Sheet 10

Consolidated Statement of Changes in Equity 11

Company Statement of Changes in Equity 12

Consolidated Cash Flow Statement 13

Notes to the Consolidated Cash Flow Statement 14

Notes to the Consolidated Financial Statements 15


SABRINA HEALTH CARE LIMITED

COMPANY INFORMATION
For The Year Ended 28 February 2023







DIRECTOR: Mr T Seeneevassen





REGISTERED OFFICE: 5&6 Manor Court
Manor Garth
Scarborough
North Yorkshire
YO11 3TU





REGISTERED NUMBER: 06366199 (England and Wales)





AUDITORS: Fortus Audit LLP
Chartered Accountants & Statutory Auditors
5&6 Manor Court
Manor Garth
Scarborough
North Yorkshire
YO11 3TU

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

GROUP STRATEGIC REPORT
For The Year Ended 28 February 2023


The director presents his strategic report of the company and the group for the year ended 28 February 2023.

REVIEW OF BUSINESS
The group's profit for the year, before interest, tax and depreciation, amounted to £847,405 (2022 - £427,731).

The director is committed to meeting the challenge of operating within the care industry and the regular changes in regulations that come with it. The business received Covid related funding during the year from local authorities to assist with infection control and rapid testing and this is reflected in the accounts with significant increased spending on agency staff and the continued investment in the properties.

PRINCIPAL RISKS AND UNCERTAINTIES
The group operates in a competitive industry with a wide choice of care options available to potential clients. The director makes full use of his extensive knowledge and experience of the sector to ensure that the group is well placed to attract new clients for its five care homes.

The East Coast continues to be an attractive location for retirement and this along with an ageing population should ensure that demand will remain high for care in the area in the future.

Changes in policies in respect of the standards of care required could have an impact on the business, but the director is committed to meeting and advancing the current standards required by the Care Quality Commission and keeping ahead of future developments.

KEY PERFORMANCE INDICATORS
The director considers that turnover, profit before interest, tax and depreciation and occupancy levels are the key performance indicators which are necessary to give an understanding of the development and performance of the business.

Turnover and occupancy levels were pretty much maintained when compared to the previous years results with support coming in the form of funding via local authority infection control and rapid testing. Staff costs increased as the business continues to invest in a long term staffing programme, assisted by a bank of agency workers. The business also invested heavily in the homes by way of a continual repairs and maintenance programme which was also a requirement of the infection control funding.

Summary of KPI's 2023 2022 2021

Turnover 4,810,676 4,147,214 4,167,538
Profit before interest, tax and
depreciation

847,405

427,731

511,824

ON BEHALF OF THE BOARD:





Mr T Seeneevassen - Director


30 April 2024

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

REPORT OF THE DIRECTOR
For The Year Ended 28 February 2023


The director presents his report with the financial statements of the company and the group for the year ended 28 February 2023.

DIVIDENDS
An interim dividend of 20 per share was paid on 31 January 2023. The director recommends that no final dividend be paid.

The total distribution of dividends for the year ended 28 February 2023 will be £ 2,000 .

DIRECTOR
Mr T Seeneevassen held office during the whole of the period from 1 March 2022 to the date of this report.

MATTERS COVERED IN THE STRATEGIC REPORT
Disclosures required under S416(4) of the Companies Act 2006 are commented upon in the Strategic Report as the directors consider them to be of strategic importance to the company. This includes consideration of the future developments of the company.

STATEMENT OF DIRECTOR'S RESPONSIBILITIES
The director is responsible for preparing the Group Strategic Report, the Report of the Director and the financial statements in accordance with applicable law and regulations.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the director is required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable him to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the director is aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and he has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the group's auditors are aware of that information.

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

REPORT OF THE DIRECTOR
For The Year Ended 28 February 2023


AUDITORS
The auditors, Fortus Audit LLP, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:



Mr T Seeneevassen - Director


30 April 2024

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
SABRINA HEALTH CARE LIMITED


Qualified opinion
We have audited the financial statements of Sabrina Health Care Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 28 February 2023 which comprise the Consolidated Statement of Comprehensive Income, Consolidated Balance Sheet, Company Balance Sheet, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Cash Flow Statement and Notes to the Consolidated Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion, except for the possible effects of the matters described in the basis for qualified opinion section of our report, the financial statements:

-give a true and fair view of the state of the group's and of the parent company's affairs as at 28
February 2023 and of the group's profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting
Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for qualified opinion
The group was unable to provide us with supporting invoices for a representative sample of costs included in repairs and renewals. We were therefore unable to satisfy ourselves over the repairs and renewals costs figure included in the profit and loss account at a value of £333,547 and the fixed asset figure included in the parent balance sheet at £75,869 and the group balance sheet at £5,692,598.

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our qualified opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and the parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the director with respect to going concern are described in the relevant sections of this report.

Other information
The director is responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Director, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
SABRINA HEALTH CARE LIMITED


Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Group Strategic Report and the Report of the Director for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Group Strategic Report and the Report of the Director have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

Arising solely from the limitation on the scope of our work relating to costs referred to above:

- We have not obtained all the information and explanations that we consider necessary for the
purposes of our audit; and
- In our opinion, adequate accounting records have not been kept.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

- returns adequate for our audit have not been received from branches not visited by us; or
- the parent company financial statements are not in agreement with the accounting records and
returns;
- or certain disclosures of director's remuneration specified by law are not made.

Responsibilities of director
As explained more fully in the Statement of Director's Responsibilities set out on page three, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the director is responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the group or the parent company or to cease operations, or has no realistic alternative but to do so.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
SABRINA HEALTH CARE LIMITED


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We obtained an understanding of the legal and regulatory frameworks that are applicable to the company and determined that the most significant frameworks which are directly relevant to specific assertions in the financial statements are those that relate to the reporting framework (UK GAAP and the Companies Act 2006) and the relevant tax compliance regulations in the UK.

We understood how the company is complying with those frameworks by making enquiries of management and those responsible for legal and compliance procedures. We corroborated our enquiries through review of board minutes and discussions with those charged with governance.

We assessed the susceptibility of the company’s financial statements to material misstatement, including how fraud might occur, by discussion with management from various parts of the business to understand where they considered there was a susceptibility to fraud. We considered the procedures and controls that the company has established to prevent and detect fraud, and how these are monitored by management, and also any enhanced risk factors such as performance targets.

Based on our understanding, we designed our audit procedures to identify any non-compliance with laws and regulations identified in the paragraphs above.

We also performed audit work over the risk of management override of controls, including testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal course of business and reviewing accounting estimates for bias.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Frances Howard FCA (Senior Statutory Auditor)
for and on behalf of Fortus Audit LLP
Chartered Accountants & Statutory Auditors
5&6 Manor Court
Manor Garth
Scarborough
North Yorkshire
YO11 3TU

30 April 2024

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

CONSOLIDATED
STATEMENT OF COMPREHENSIVE
INCOME
For The Year Ended 28 February 2023

2023 2022
as restated
Notes £    £   

TURNOVER 4,810,676 4,147,214

Cost of sales 3,172,381 2,834,903
GROSS PROFIT 1,638,295 1,312,311

Administrative expenses 1,019,101 1,109,678
619,194 202,633

Other operating income 16,610 7,316
OPERATING PROFIT 4 635,804 209,949


Interest payable and similar expenses 5 127,472 78,525
PROFIT BEFORE TAXATION 508,332 131,424

Tax on profit 6 192,102 33,924
PROFIT FOR THE FINANCIAL YEAR 316,230 97,500

OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME FOR THE
YEAR

316,230

97,500

Profit attributable to:
Owners of the parent 316,230 97,500

Total comprehensive income attributable to:
Owners of the parent 316,230 97,500

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

CONSOLIDATED BALANCE SHEET
28 February 2023

2023 2022
as restated
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 10 294,995 353,993
Tangible assets 11 5,692,598 5,837,040
Investments 12 - -
5,987,593 6,191,033

CURRENT ASSETS
Stocks 13 1,500 1,500
Debtors 14 240,440 260,745
Cash at bank 142,366 51,685
384,306 313,930
CREDITORS
Amounts falling due within one year 15 935,516 655,142
NET CURRENT LIABILITIES (551,210 ) (341,212 )
TOTAL ASSETS LESS CURRENT LIABILITIES 5,436,383 5,849,821

CREDITORS
Amounts falling due after more than
one year

16

(2,264,793

)

(3,051,619

)

PROVISIONS FOR LIABILITIES 19 (359,181 ) (300,023 )
NET ASSETS 2,812,409 2,498,179

CAPITAL AND RESERVES
Called up share capital 20 100 100
Revaluation reserve 21 856,237 990,750
Retained earnings 21 1,956,072 1,507,329
SHAREHOLDERS' FUNDS 2,812,409 2,498,179

The financial statements were approved by the director and authorised for issue on 30 April 2024 and were signed by:





Mr T Seeneevassen - Director


SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

COMPANY BALANCE SHEET
28 February 2023

2023 2022
as restated
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 10 - -
Tangible assets 11 75,869 81,710
Investments 12 3,040,944 3,040,944
3,116,813 3,122,654

CURRENT ASSETS
Stocks 13 1,500 1,500
Debtors 14 3,118,741 3,139,046
Cash at bank 142,366 51,685
3,262,607 3,192,231
CREDITORS
Amounts falling due within one year 15 935,516 655,141
NET CURRENT ASSETS 2,327,091 2,537,090
TOTAL ASSETS LESS CURRENT LIABILITIES 5,443,904 5,659,744

CREDITORS
Amounts falling due after more than
one year

16

(2,264,793

)

(3,051,620

)

PROVISIONS FOR LIABILITIES 19 (18,967 ) (15,525 )
NET ASSETS 3,160,144 2,592,599

CAPITAL AND RESERVES
Called up share capital 20 100 100
Retained earnings 21 3,160,044 2,592,499
SHAREHOLDERS' FUNDS 3,160,144 2,592,599

Company's profit for the financial year 569,545 274,345

The financial statements were approved by the director and authorised for issue on 30 April 2024 and were signed by:





Mr T Seeneevassen - Director


SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
For The Year Ended 28 February 2023

Called up
share Retained Revaluation Total
capital earnings reserve equity
£    £    £    £   
Balance at 1 March 2021 100 1,358,967 1,043,612 2,402,679

Changes in equity
Dividends - (2,000 ) - (2,000 )
Total comprehensive income - 150,362 (52,862 ) 97,500
Balance at 28 February 2022 100 1,507,329 990,750 2,498,179

Changes in equity
Dividends - (2,000 ) - (2,000 )
Total comprehensive income - 450,743 (134,513 ) 316,230
Balance at 28 February 2023 100 1,956,072 856,237 2,812,409

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

COMPANY STATEMENT OF CHANGES IN EQUITY
For The Year Ended 28 February 2023

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 March 2021 100 2,320,154 2,320,254

Changes in equity
Dividends - (2,000 ) (2,000 )
Total comprehensive income - 274,345 274,345
Balance at 28 February 2022 100 2,592,499 2,592,599

Changes in equity
Dividends - (2,000 ) (2,000 )
Total comprehensive income - 569,545 569,545
Balance at 28 February 2023 100 3,160,044 3,160,144

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

CONSOLIDATED CASH FLOW STATEMENT
For The Year Ended 28 February 2023

2023 2022
as restated
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 906,884 405,242
Interest paid (127,472 ) (78,525 )
Tax paid (91,581 ) (68,020 )
Net cash from operating activities 687,831 258,697

Cash flows from investing activities
Purchase of tangible fixed assets (8,161 ) (29,635 )
Net cash from investing activities (8,161 ) (29,635 )

Cash flows from financing activities
Bank loan repayments in year (672,219 ) (300,977 )
Loans to related parties (21,566 ) -
Amount introduced by directors 615,412 201,391
Amounts withdrawn by directors (508,616 ) (305,249 )
Equity dividends paid (2,000 ) (2,000 )
Net cash from financing activities (588,989 ) (406,835 )

Increase/(decrease) in cash and cash equivalents 90,681 (177,773 )
Cash and cash equivalents at beginning
of year

2

51,685

229,458

Cash and cash equivalents at end of
year

2

142,366

51,685

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED CASH FLOW STATEMENT
For The Year Ended 28 February 2023


1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS
2023 2022
as restated
£    £   
Profit before taxation 508,332 131,424
Depreciation charges 211,601 217,782
Finance costs 127,472 78,525
847,405 427,731
Increase in trade and other debtors (64,925 ) (12,327 )
Increase/(decrease) in trade and other creditors 124,404 (10,162 )
Cash generated from operations 906,884 405,242

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 28 February 2023
28.2.23 1.3.22
£    £   
Cash and cash equivalents 142,366 51,685
Year ended 28 February 2022
28.2.22 1.3.21
as restated
£    £   
Cash and cash equivalents 51,685 229,458


3. ANALYSIS OF CHANGES IN NET DEBT

At 1.3.22 Cash flow At 28.2.23
£    £    £   
Net cash
Cash at bank 51,685 90,681 142,366
51,685 90,681 142,366
Debt
Debts falling due within 1 year (282,404 ) (114,607 ) (397,011 )
Debts falling due after 1 year (3,051,619 ) 786,826 (2,264,793 )
(3,334,023 ) 672,219 (2,661,804 )
Total (3,282,338 ) 762,900 (2,519,438 )

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For The Year Ended 28 February 2023


1. STATUTORY INFORMATION

Sabrina Health Care Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the General Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Basis of consolidation
The consolidated accounts incorporate the accounts of Sabrina Health Care Limited and its subsidiary and all figures used relate to the year ended 28 February 2023.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover is derived from care home fees and all arises from activities carried on in the United Kingdom.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Goodwill arising on the acquisition of the subsidiary is being amortised over 20 years on a straight line basis.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - Land 0%, buildings 4% on cost
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 20% on reducing balance
Computer equipment - 20% on cost

Stocks
Stocks relate to food and medical provisions in the homes and are valued at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Statement of Comprehensive Income, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
For The Year Ended 28 February 2023


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate.

Going concern
The director has considered the impact of rising energy costs and minimum wage increases in relation to their assessment of going concern and in their opinion have taken all reasonable steps to mitigate these factors. As at the point of authorising the accounts, and for the foreseeable future, the director considers the going concern assumption to still be appropriate. The director acknowledges that given the currently rapidly changing business and social environment, there are likely to be significant unknown factors which may present themselves. Such factors are considered by the director to represent a general inherent level of risk in relation to the going concern assumption albeit not quantifiable at this time

The director has a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future. Thus he continues to adopt the going concern basis of accounting in preparing the financial statements.

Government grants
Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the company will comply with conditions attaching to them and the grants will be received using the accrual model.

Debtors and creditors receivable / payable within one year
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

3. EMPLOYEES AND DIRECTORS
2023 2022
as restated
£    £   
Wages and salaries 2,536,406 2,302,015
Social security costs 208,823 170,867
Other pension costs 39,242 38,026
2,784,471 2,510,908

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
For The Year Ended 28 February 2023


3. EMPLOYEES AND DIRECTORS - continued

The average number of employees during the year was as follows:
2023 2022
as restated

Directors 1 1
Administration and management 2 2
Nursing and kitchen 128 125
131 128

2023 2022
as restated
£    £   
Director's remuneration 24,000 24,000

Key management personnel is considered to be the director of the company.

4. OPERATING PROFIT

The operating profit is stated after charging:

2023 2022
as restated
£    £   
Hire of plant and machinery 2,246 7,090
Depreciation - owned assets 152,603 153,973
Goodwill amortisation 58,998 63,809
Auditors' remuneration 9,684 9,720
Auditors' remuneration for non audit work 11,032 12,468

5. INTEREST PAYABLE AND SIMILAR EXPENSES
2023 2022
as restated
£    £   
Bank loan interest 126,176 77,098
Other interest 1,296 1,427
127,472 78,525

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
For The Year Ended 28 February 2023


6. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2023 2022
as restated
£    £   
Current tax:
UK corporation tax 132,944 57,078

Deferred tax 59,158 (23,154 )
Tax on profit 192,102 33,924

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2023 2022
as restated
£    £   
Profit before tax 508,332 131,424
Profit multiplied by the standard rate of corporation tax in the UK
of 19 % (2022 - 19 %)

96,583

24,971

Effects of:
Capital allowances in excess of depreciation (5,099 ) -
Depreciation in excess of capital allowances - 8,953
Deferred tax due to increase in tax rate 100,618 -
Total tax charge 192,102 33,924

Factors that may affect future tax charges
The Finance Act 2021 was substantively enacted in May 2021 and has increased the corporation tax rate from 19% to 25% with effect from 1 April 2023. The deferred taxation balances have been measured using the rates expected to apply in the reporting periods when the timing differences reverse.

7. INDIVIDUAL STATEMENT OF COMPREHENSIVE INCOME

As permitted by Section 408 of the Companies Act 2006, the Statement of Comprehensive Income of the parent company is not presented as part of these financial statements.


8. DIVIDENDS
2023 2022
as restated
£    £   
Ordinary shares of 1 each
Interim 2,000 2,000

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
For The Year Ended 28 February 2023


9. PRIOR YEAR ADJUSTMENT

During the year it has come to the attention of the Director that loan payments made by a related entity and payments made to the Director were not appropriately recorded. The error is considered material and therefore the comparative figures have been restated. This has had the effect of reducing amounts due from related entities by £150,000, increasing amounts due from the Director by £77,615 and reducing bank loans due after more than one year by £72,385 in both the parent and group figures.

10. INTANGIBLE FIXED ASSETS

Group
Goodwill
£   
COST
At 1 March 2022
and 28 February 2023 1,273,882
AMORTISATION
At 1 March 2022 919,889
Amortisation for year 58,998
At 28 February 2023 978,887
NET BOOK VALUE
At 28 February 2023 294,995
At 28 February 2022 353,993

11. TANGIBLE FIXED ASSETS

Group
Fixtures
Freehold and Motor Computer
property fittings vehicles equipment Totals
£    £    £    £    £   
COST
At 1 March 2022 6,825,135 387,035 18,450 1,050 7,231,670
Additions - 6,702 - 1,459 8,161
At 28 February 2023 6,825,135 393,737 18,450 2,509 7,239,831
DEPRECIATION
At 1 March 2022 1,083,792 297,679 12,483 676 1,394,630
Charge for year 136,502 14,406 1,193 502 152,603
At 28 February 2023 1,220,294 312,085 13,676 1,178 1,547,233
NET BOOK VALUE
At 28 February 2023 5,604,841 81,652 4,774 1,331 5,692,598
At 28 February 2022 5,741,343 89,356 5,967 374 5,837,040

All of the properties were last revalued on the 25th November 2014 by Edward Symmons LLP independent chartered surveyors. Upon transition to FRS102, this was taken to be deemed cost.

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
For The Year Ended 28 February 2023


11. TANGIBLE FIXED ASSETS - continued

Company
Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 March 2022 168,421 18,450 1,050 187,921
Additions 6,702 - 1,459 8,161
At 28 February 2023 175,123 18,450 2,509 196,082
DEPRECIATION
At 1 March 2022 93,052 12,483 676 106,211
Charge for year 12,307 1,193 502 14,002
At 28 February 2023 105,359 13,676 1,178 120,213
NET BOOK VALUE
At 28 February 2023 69,764 4,774 1,331 75,869
At 28 February 2022 75,369 5,967 374 81,710

12. FIXED ASSET INVESTMENTS

Company
Shares in
group
undertakings
£   
COST
At 1 March 2022
and 28 February 2023 3,040,944
NET BOOK VALUE
At 28 February 2023 3,040,944
At 28 February 2022 3,040,944

The group or the company's investments at the Balance Sheet date in the share capital of companies include the following:

Subsidiary

Hexon Limited
Registered office: 5&6 Manor Court, Manor Garth, Scarborough, YO11 3TU.
Nature of business: Non trading
%
Class of shares: holding
Ordinary 100.00
2023 2022
£    £   
Aggregate capital and reserves 2,398,214 2,592,531
Loss for the year (194,317 ) (117,847 )


SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
For The Year Ended 28 February 2023


13. STOCKS

Group Company
2023 2022 2023 2022
as
restated
as
restated
£    £    £    £   
Stocks 1,500 1,500 1,500 1,500

14. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2023 2022 2023 2022
as
restated
as
restated
£    £    £    £   
Trade debtors 188,875 123,950 188,875 123,950
Amounts owed by group undertakings - - 2,878,301 2,878,301
Amounts owed by related parties 21,566 - 21,566 -
Director' loan account 29,999 136,795 29,999 136,795
240,440 260,745 3,118,741 3,139,046

15. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2023 2022 2023 2022
as
restated
as
restated
£    £    £    £   
Bank loans and overdrafts (see note 17) 397,011 282,404 397,011 282,404
Deferred income 128,054 38,896 128,054 38,896
Trade creditors 15,134 7,493 15,134 7,492
Corporation tax 150,690 109,327 150,690 109,327
Social security and other taxes 39,427 38,121 39,427 38,121
Other creditors 185,711 163,284 185,711 163,284
Accrued expenses 19,489 15,617 19,489 15,617
935,516 655,142 935,516 655,141

16. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

Group Company
2023 2022 2023 2022
as
restated
as
restated
£    £    £    £   
Bank loans (see note 17) 2,264,793 3,051,619 2,264,793 3,051,620

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
For The Year Ended 28 February 2023


17. LOANS

An analysis of the maturity of loans is given below:

Group Company
2023 2022 2023 2022
as
restated
as
restated
£    £    £    £   
Amounts falling due within one year or on demand:
Bank loans 397,011 282,404 397,011 282,404
Amounts falling due between one and two years:
Bank loans 382,454 250,062 382,454 250,063
Amounts falling due between two and five years:
Bank loans 1,208,960 886,649 1,208,960 886,649
Amounts falling due in more than five years:
Repayable by instalments
Bank loans 673,379 1,914,908 673,379 1,914,908

The loan repayment terms are monthly instalments and the interest rate is charged at 1.95% above base rate.

18. SECURED DEBTS

The following secured debts are included within creditors:

Company
2023 2022
as restated
£    £   
Bank loans 2,661,804 3,334,024

The company has given as security a first legal charge over the groups freehold land and buildings.

19. PROVISIONS FOR LIABILITIES

Group Company
2023 2022 2023 2022
as
restated
as
restated
£    £    £    £   
Deferred tax 359,181 300,023 18,967 15,525

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
For The Year Ended 28 February 2023


19. PROVISIONS FOR LIABILITIES - continued

Group
Deferred
tax
£   
Balance at 1 March 2022 300,023
Accelerated capital allowances 59,158
Balance at 28 February 2023 359,181

Company
Deferred
tax
£   
Balance at 1 March 2022 15,525
Accelerated capital allowances 3,442
Balance at 28 February 2023 18,967

20. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: as
restated
£    £   
100 Ordinary 1 100 100

21. RESERVES

Group
Retained Revaluation
earnings reserve Totals
£    £    £   

At 1 March 2022 1,507,329 990,750 2,498,079
Profit for the year 316,230 316,230
Dividends (2,000 ) (2,000 )
Deferred tax adjustment 55,716 (55,716 ) -
Depreciation movement 78,797 (78,797 ) -
At 28 February 2023 1,956,072 856,237 2,812,309

Company
Retained
earnings
£   

At 1 March 2022 2,592,499
Profit for the year 569,545
Dividends (2,000 )
At 28 February 2023 3,160,044

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
For The Year Ended 28 February 2023


21. RESERVES - continued


22. PENSION COMMITMENTS

The group operates a work place defined contribution pension scheme for the benefit of employees who have opted in. The assets of the scheme are administered by trustees in a fund independent from those of the group. The total contributions paid in the year amounted to £39,242 (2022 - £38,026).

23. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 28 February 2023 and 28 February 2022:

2023 2022
as restated
£    £   
Mr T Seeneevassen
Balance outstanding at start of year 136,795 32,937
Amounts advanced 376,265 376,567
Amounts repaid (483,061 ) (272,709 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 29,999 136,795

No interest is accruing on the directors loan account.

24. RELATED PARTY DISCLOSURES

Hexon Limited has provided assets as security against the parent company's borrowing.

Debtors includes a loan of £21,566 (2022 - nil) to a related company, Aalia Health Care Limited.

During the year, the group paid rent of £24,000 (2022 - £24,000) to the director for the use of head office premises.

25. ULTIMATE CONTROLLING PARTY

The group is controlled by its sole director, Mr T Seeneevassen, who owns 100% of the share capital.